Logotype for Colgate-Palmolive Company

Colgate-Palmolive Company (CL) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Colgate-Palmolive Company

Q4 2025 earnings summary

2 Feb, 2026

Executive summary

  • Achieved stronger-than-expected Q4 and 2025 results, with net sales and organic sales up 1.4% year-over-year, driven by oral care and pet nutrition, despite lower category growth, raw material inflation, and higher tariffs.

  • Fourth quarter saw accelerated growth: net sales up 5.8%, organic sales up 2.2%, and Base Business EPS up 4% compared to Q3.

  • Transitioned from the 2025 strategy, which added $5B in sales, to a new 2030 strategy focused on brand strength, innovation, omni-channel demand generation, digital/data/AI investments, supply chain optimization, and culture.

  • Launched the Strategic Growth and Productivity Program (SGPP) to unlock organizational changes and funding for the new strategy, targeting $200–$300 million in pre-tax charges.

  • Record operating cash flow of $4.2B and $2.9B returned to shareholders through dividends and share repurchases in 2025.

Financial highlights

  • Net sales and organic sales increased 1.4% for 2025, with a 0.7% negative impact from exiting private label pet food.

  • Q4 organic sales grew over 3% excluding private label and Prime100 acquisition impacts; Hill's segment posted over 5% organic sales growth (ex-private label).

  • Base Business EPS rose 3% year-over-year; Q4 Base Business EPS up 4% sequentially.

  • Free cash flow reached $3.5B–$3.6B in 2025.

  • Global toothpaste market share up 10 basis points to 41.3% and manual toothbrush share up 60 basis points to 32.4% year-to-date.

Outlook and guidance

  • 2026 net sales growth expected at 2% to 6%, with organic sales growth of 1% to 4% and a low-single-digit positive FX impact.

  • Gross profit margin and advertising spend expected to increase; GAAP EPS projected to rise double digits, Base Business EPS up low to mid-single digits.

  • Guidance includes a 20 basis point drag from exiting private label pet food.

  • No major rebound assumed in the U.S.; trends expected to improve gradually.

  • Focus on investing in brands, innovation, and capabilities, with flexibility to adjust spend as needed.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more